HansBiomed Statistics

Total Valuation

HansBiomed has a market cap or net worth of KRW 108.31 billion. The enterprise value is 139.18 billion.

Market Cap	108.31B
Enterprise Value	139.18B

Important Dates

The last earnings date was Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

HansBiomed has 12.99 million shares outstanding. The number of shares has increased by 20.83% in one year.

Current Share Class	n/a
Shares Outstanding	12.99M
Shares Change (YoY)	+20.83%
Shares Change (QoQ)	-0.28%
Owned by Insiders (%)	26.25%
Owned by Institutions (%)	0.77%
Float	7.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.34
PB Ratio	1.68
P/TBV Ratio	1.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 144.98, with an EV/FCF ratio of -44.50.

EV / Earnings	-17.31
EV / Sales	1.73
EV / EBITDA	144.98
EV / EBIT	n/a
EV / FCF	-44.50

Financial Position

The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.57.

Current Ratio	0.99
Quick Ratio	0.35
Debt / Equity	0.57
Debt / EBITDA	7.82
Debt / FCF	-11.64
Interest Coverage	-0.41

Financial Efficiency

Return on equity (ROE) is -12.70% and return on invested capital (ROIC) is -0.45%.

Return on Equity (ROE)	-12.70%
Return on Assets (ROA)	-0.38%
Return on Invested Capital (ROIC)	-0.45%
Return on Capital Employed (ROCE)	-1.07%
Revenue Per Employee	635.07M
Profits Per Employee	-63.32M
Employee Count	127
Asset Turnover	0.67
Inventory Turnover	1.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.00% in the last 52 weeks. The beta is 0.68, so HansBiomed's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-33.00%
50-Day Moving Average	8,545.00
200-Day Moving Average	10,106.00
Relative Strength Index (RSI)	48.13
Average Volume (20 Days)	14,684

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HansBiomed had revenue of KRW 80.65 billion and -8.04 billion in losses. Loss per share was -620.95.

Revenue	80.65B
Gross Profit	50.54B
Operating Income	-735.76M
Pretax Income	-6.56B
Net Income	-8.04B
EBITDA	4.65B
EBIT	-735.76M
Loss Per Share	-620.95

Full Income Statement

Balance Sheet

The company has 5.54 billion in cash and 36.40 billion in debt, giving a net cash position of -30.86 billion or -2,376.18 per share.

Cash & Cash Equivalents	5.54B
Total Debt	36.40B
Net Cash	-30.86B
Net Cash Per Share	-2,376.18
Equity (Book Value)	64.29B
Book Value Per Share	4,949.73
Working Capital	-675.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -496.44 million and capital expenditures -2.63 billion, giving a free cash flow of -3.13 billion.

Operating Cash Flow	-496.44M
Capital Expenditures	-2.63B
Free Cash Flow	-3.13B
FCF Per Share	-240.83

Full Cash Flow Statement

Margins

Gross margin is 62.67%, with operating and profit margins of -0.91% and -9.97%.

Gross Margin	62.67%
Operating Margin	-0.91%
Pretax Margin	-8.13%
Profit Margin	-9.97%
EBITDA Margin	5.77%
EBIT Margin	-0.91%
FCF Margin	n/a

Dividends & Yields

HansBiomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.83%
Shareholder Yield	-20.83%
Earnings Yield	-7.42%
FCF Yield	-2.89%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HansBiomed has an Altman Z-Score of 2.07. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.07
Piotroski F-Score	n/a